Gastroenterology
Rabsal DSR
Delayed-release combination of Rabeprazole Sodium and Domperidone. Rabeprazole provides proton pump inhibition for acid suppression, while Domperidone acts as a prokinetic agent to reduce gastroparesis and reflux. Indicated in GERD, peptic ulcers, and functional dyspepsia.
Benefits
Dual-action: PPI + prokinetic
Effective in GERD and acid reflux
Reduces gastroparesis and bloating
Heals peptic and duodenal ulcers
Delayed-release for optimum acid suppression
Prescription Required
This is a Schedule H medicine. It must be dispensed only against a valid prescription
from a registered medical practitioner.